TABLE 4.
Vector envelopea | Target cell | Soluble SUb | Titer (105 BFU/ml)c |
---|---|---|---|
GALV | MDTF | None | <0.001 |
MDTF-Pit1 | None | 50.0 ± 0.6 | |
GALV I10 | MDTF | None | <0.001 |
MDTF-Pit1 | None | <0.001 | |
GALV I10 | MDTF | FeLV-B1-444 | <0.001 |
MDTF-Pit1 | FeLV-B1-444 | <0.001 | |
GALV I10 | MDTF | GALV1-219 | <0.001 |
MDTF-Pit1 | GALV1-219 | 0.8 ± 0.3 | |
GALV I10 | MDTF | GALV1-264 | <0.001 |
MDTF-Pit1 | GALV1-264 | 1.2 ± 0.2 | |
GALV I10 | MDTF | A-MLV1-448 | <0.001 |
MDTF-Pit1 | A-MLV1-448 | <0.001 |
Viral vectors were produced from transiently transfected 293T cells as described in Materials and Methods. GALV I10 contains the C11D8 epitope inserted at position 10 of the SU.
Target cells were incubated with equal volumes of vector particle supernatants and medium containing soluble SU proteins.
Titers are expressed as the average numbers of blue foci (BFU) ± standard errors of the means from three experiments.